A patient suffering from cancer receives treatment as part of a clinical trial of chemotherapy drugs at the Acharya Tulsi Regional Cancer Treatment and Research Center February 27, 2009 in Bikaner, India. India increasingly emerges as a preferred destination for outsourcing clinical trials - testing of new drugs on humans with the cost of conducting trials in India being 20% to 60% of the cost in industrialized countries..While the market value of clinical trial research outsourced to India is presently estimated at $300 million, having increased by 65% in 2006 alone, the value is expected to become $1.5-2 billion by 2010. .Factors such as a diverse genetic pool, large patient pool, drug naive population, competent medical professionals and high quality hospitals where trials can be undertaken, low cost of services have stimulated the increased flow of clinical research in India.